AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2020
Jun 4, 2020
30610_dirs_2020-06-04_7f6f3597-e9e5-4773-b84a-f16ec52da999.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-26
Reporting Person: Hoge Stephen (President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-26 | Common Stock | S | 200 | $66.11 | Disposed | 1996540 | Direct |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018.
More from Moderna, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 23
Annual Report
2026
Feb 20
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13